IRCT20100314003565N9招募中3 期
Evaluating the effect of Cabergoline on blood glucose control in type 2 diabetics under treatment with Metformin
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 65 years（—）
- 性别
- All
入选标准
- •A type 2 diabetic patient with a history of at least 3 months receiving metformin at a dose of 2 g / day
- •Age from 30 to 65 years
- •HbA1C levels in the range of 7- 8.5
- •Obtaining Conscious Consent from all Participants involved in the Study
排除标准
- •The presence of other diseases (cardiovascular, kidney, liver, lung, thyroid and pituitary diseases)
- •Taking herbal remedies
- •Taking other diabetes controller drugs
研究者
相似试验
已完成
3 期
Treatment of uterine myoma.fibromyoma of uterus.Leiomyoma of uterusfibromyoma of uterusIRCT201403092624N12Vice chancellor for research ,Iran University of Medical Sciences.50
已完成
2 期
Effect of Cabergoline on biochemical and anthropometric parameters of patients with prediabetes.Impaired Glucose Tolerance/Impaired Fasting Glucos.Impaired glucose tolerance (oral)R73.02IRCT20170608034390N6Shahid Beheshti University of Medical Sciences98
尚未招募
Unknown
Comparison of the effect of Cabergoline versus Dienogest on markers in endometriosisCTRI/2023/04/051886il
尚未招募
Unknown
To study the benefits of addition of Cabergoline to Metformin in women with PCOSCTRI/2024/08/071776il
招募中
2 期
Effect of Cabergoline on biochemical and anthropometric parameters of patient with Impaired Glucose metabolism (Impaired Fasting Glucose/Impaired Glucose Tolerance)Metabolic and Endocrine - Metabolic disordersPrediabetesACTRN12613001121752Shahid Beheshti University of Medical Sciences70